360 related articles for article (PubMed ID: 32188806)
1. Determinants of Insufficient Optimal Medical Therapy after Acute Myocardial Infarction.
Haraguchi Y; Sakakura K; Yamamoto K; Taniguchi Y; Tsukui T; Seguchi M; Wada H; Momomura SI; Fujita H
Intern Med; 2020 Jun; 59(12):1489-1495. PubMed ID: 32188806
[TBL] [Abstract][Full Text] [Related]
2. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
Lee HY; Cooke CE; Robertson TA
J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
[TBL] [Abstract][Full Text] [Related]
3. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
[TBL] [Abstract][Full Text] [Related]
4. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous coronary intervention vs. optimal medical therapy--the other side of the coin: medication adherence.
Kocas C; Abaci O; Oktay V; Coskun U; Bostan C; Yildiz A; Arat Ozkan A; Gurmen T; Ersanli M
J Clin Pharm Ther; 2013 Dec; 38(6):476-9. PubMed ID: 23992279
[TBL] [Abstract][Full Text] [Related]
6. Angiography-guided Multivessel Percutaneous Coronary Intervention Versus Ischemia-guided Percutaneous Coronary Intervention Versus Medical Therapy in the Management of Significant Disease in Non-Infarct-related Arteries in ST-Elevation Myocardial Infarction Patients With Multivessel Coronary Disease.
Perera D; Crake T; Lee V
Crit Pathw Cardiol; 2018 Jun; 17(2):77-82. PubMed ID: 29768315
[TBL] [Abstract][Full Text] [Related]
7. Impact of Optimal Medical Therapy at Discharge on One-year Direct Medical Costs in Patients with Acute Coronary Syndromes: A Retrospective, Observational Database Analysis in China.
He X; Wang Y; Cong H; Lu C; Wu J
Clin Ther; 2019 Mar; 41(3):456-465.e2. PubMed ID: 30770126
[TBL] [Abstract][Full Text] [Related]
8. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
[TBL] [Abstract][Full Text] [Related]
9. The impact of in-hospital cardiac rehabilitation program on medication adherence and clinical outcomes in patients with acute myocardial infarction in the Lazio region of Italy.
Soldati S; Di Martino M; Rosa AC; Fusco D; Davoli M; Mureddu GF
BMC Cardiovasc Disord; 2021 Sep; 21(1):466. PubMed ID: 34565326
[TBL] [Abstract][Full Text] [Related]
10. Contemporary Trends of Optimal Evidence-Based Medical Therapy at Discharge for Patients Surviving Acute Myocardial Infarction From the Korea Acute Myocardial Infarction Registry.
Lee JH; Bae MH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Cho MC; Kim CJ; Chae SC;
Clin Cardiol; 2015 Jun; 38(6):350-6. PubMed ID: 25962712
[TBL] [Abstract][Full Text] [Related]
11. Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction.
Arnold SV; Spertus JA; Masoudi FA; Daugherty SL; Maddox TM; Li Y; Dodson JA; Chan PS
J Am Coll Cardiol; 2013 Nov; 62(19):1791-801. PubMed ID: 23973701
[TBL] [Abstract][Full Text] [Related]
12. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Medication Use in Patients with Acute Myocardial Infarction and Nonobstructive Coronary Artery Disease.
Adatia F; Galway S; Grubisic M; Lee M; Daniele P; Humphries KH; Sedlak TL
J Womens Health (Larchmt); 2017 Nov; 26(11):1185-1192. PubMed ID: 28384014
[TBL] [Abstract][Full Text] [Related]
14. Impact of Optimal Medical Therapy in the Dual Antiplatelet Therapy Study.
Resor CD; Nathan A; Kereiakes DJ; Yeh RW; Massaro JM; Cutlip DE; Gabriel Steg P; Hsieh WH; Mauri L;
Circulation; 2016 Oct; 134(14):989-998. PubMed ID: 27576774
[TBL] [Abstract][Full Text] [Related]
15. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions.
Werner GS; Martin-Yuste V; Hildick-Smith D; Boudou N; Sianos G; Gelev V; Rumoroso JR; Erglis A; Christiansen EH; Escaned J; di Mario C; Hovasse T; Teruel L; Bufe A; Lauer B; Bogaerts K; Goicolea J; Spratt JC; Gershlick AH; Galassi AR; Louvard Y;
Eur Heart J; 2018 Jul; 39(26):2484-2493. PubMed ID: 29722796
[TBL] [Abstract][Full Text] [Related]
16. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Quality of Prescription for ST-Segment Elevation Myocardial Infarction (STEMI) Patients: A Real World 1-Year Follow-Up Study.
Bruggmann C; Iglesias JF; Gex-Fabry M; Fesselet R; Vogt P; Sadeghipour F; Voirol P
Am J Cardiovasc Drugs; 2020 Feb; 20(1):105-115. PubMed ID: 31300969
[TBL] [Abstract][Full Text] [Related]
18. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
Björck L; Wallentin L; Stenestrand U; Lappas G; Rosengren A
Arch Intern Med; 2010 Aug; 170(15):1375-81. PubMed ID: 20696964
[TBL] [Abstract][Full Text] [Related]
19. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
Lee JH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH; Chae SC;
Am Heart J; 2010 Jun; 159(6):1012-9. PubMed ID: 20569714
[TBL] [Abstract][Full Text] [Related]
20. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
